Mariel M Velez, MD
Neurology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Velez’s office at (916) 973-5000 to ask if they take your plan before you enroll.
Medicaid work
$35 in 2020
Medicaid paid $35 for 12 billed services this clinician did in 2020, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 12 | $35 |
| 2020 | 12 | 1 | 12 | $35 |
Drugs they prescribed that Part D paid
$102,817
Pharmacies billed $102,817 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 421) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
359 generic and fewer than 11 brand-name prescriptions · $102,817 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Briviact | 29 | $44,298 | $1,528 |
| Dilantin | 16 | $4,660 | $291 |
| Levetiracetam | 77 | $3,905 | $51 |
| Lacosamide | 42 | $3,562 | $85 |
| Clobazam | 35 | $2,824 | $81 |
See all 9 drugs
| Briviact | 29 | $44,298 | $1,528 |
| Dilantin | 16 | $4,660 | $291 |
| Levetiracetam | 77 | $3,905 | $51 |
| Lacosamide | 42 | $3,562 | $85 |
| Clobazam | 35 | $2,824 | $81 |
| Oxcarbazepine | 11 | $2,339 | $213 |
| Lamotrigine | 48 | $1,375 | $29 |
| Phenytoin Sodium Extended | 20 | $1,124 | $56 |
| Divalproex | 17 | $750 | $44 |
Year by year
| 2024 | 421 | 96 | 0% (0) | None | $102,817 |
| 2023 | 288 | 75 | 0% (0) | None | $69,465 |
| 2022 | 396 | 120 | 0% (0) | None | $174,776 |
| 2021 | 1,215 | 142 | 0% (0) | 46% | $1,106,388 |
| 2020 | 380 | 98 | 0% (0) | 43% | $312,249 |
| 2019 | 229 | 48 | 0% (0) | 19% | $76,019 |
| 2018 | 118 | 30 | 0% (0) | 12% | $25,010 |
| 2016 | 15 | None | 0% (0) | None | $8,011 |
| 2015 | 18 | None | 0% (0) | 78% | $8,670 |
| 2014 | 20 | None | 0% (0) | None | $2,359 |
| 2013 | 15 | None | 0% (0) | 73% | $5,392 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Briviact | 22 | $43,065 | $1,957 |
| Clobazam | 12 | $7,192 | $599 |
| Lacosamide | 47 | $6,796 | $145 |
| Levetiracetam | 76 | $5,195 | $68 |
| Lamotrigine | 29 | $1,100 | $38 |
2022: 8 drugs
| Vimpat | 22 | $37,660 | $1,712 |
| Briviact | 16 | $32,510 | $2,032 |
| Lamictal | 20 | $29,077 | $1,454 |
| Levetiracetam Er | 17 | $5,985 | $352 |
| Levetiracetam | 86 | $5,319 | $62 |
| Lacosamide | 22 | $2,405 | $109 |
| Lamotrigine | 62 | $1,584 | $26 |
| Zonisamide | 19 | $1,149 | $60 |
2021: 19 drugs
| Vimpat | 250 | $428,980 | $1,716 |
| Briviact | 125 | $223,814 | $1,791 |
| Fycompa | 61 | $77,163 | $1,265 |
| Lamictal | 34 | $70,482 | $2,073 |
| Aptiom | 15 | $48,282 | $3,219 |
| Keppra | 16 | $25,390 | $1,587 |
| Levetiracetam | 205 | $13,700 | $67 |
| Clobazam | 42 | $11,812 | $281 |
| Levetiracetam Er | 40 | $7,972 | $199 |
| Depakote Er | 22 | $6,950 | $316 |
| Lamotrigine | 101 | $3,344 | $33 |
| Divalproex Sodium Er | 14 | $3,070 | $219 |
| Divalproex | 24 | $2,060 | $86 |
| Pregabalin | 12 | $1,734 | $144 |
| Zonisamide | 33 | $1,499 | $45 |
| Gabapentin | 53 | $1,009 | $19 |
| Topiramate | 29 | $492 | $17 |
| Trazodone | 24 | $177 | $7 |
| Lorazepam | 21 | $164 | $8 |
2020: 8 drugs
| Vimpat | 93 | $134,936 | $1,451 |
| Briviact | 30 | $63,881 | $2,129 |
| Fycompa | 18 | $18,667 | $1,037 |
| Lamotrigine Er | 11 | $8,262 | $751 |
| Levetiracetam | 87 | $3,523 | $40 |
| Levetiracetam Er | 12 | $1,841 | $153 |
| Lamotrigine | 32 | $1,148 | $36 |
| Gabapentin | 22 | $428 | $19 |
2019: 5 drugs
| Briviact | 15 | $31,104 | $2,074 |
| Vimpat | 20 | $23,522 | $1,176 |
| Levetiracetam | 92 | $1,793 | $19 |
| Lamotrigine | 15 | $369 | $25 |
| Gabapentin | 11 | $174 | $16 |
2018: 1 drug
| Levetiracetam | 58 | $904 | $16 |
Money from drug and device companies
$200 in 2024
| 2024 | 1 | 2 | None | $200 |
| 2023 | 1 | 1 | None | $26 |
| 2022 | 1 | 1 | None | $136 |
| 2021 | 1 | 1 | None | $23 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 13 | 51 | None | $2,007 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neuropace | Rns Neurostimulator Kit | $200 | 2 payments
|
See all 2 published payments
| Neuropace | Meals · 2024-12-08 | Rns Neurostimulator Kit | $178 |
| Neuropace | Meals · 2024-03-20 | Rns Neurostimulator Kit | $22 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $26
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $26 | 1 payment
|
2022: $136
| Jazz Pharmaceuticals | Epidiolex | $136 | 1 payment
|
2021: $23
| SK Life Science | None | $23 | 1 payment
|
2020: $21
| Medtronic USA | Activa | $21 | 1 payment
|
2019: $2,007
| LivaNova USA | Vns Therapy | $902 | 12 payments
|
| Lilly USA | Emgality | $201 | 6 payments
|
| Greenwich Biosciences | Epidiolex | $177 | 3 payments
|
| Eisai | Fycompa | $174 | 8 payments
|
| Amgen | Aimovig | $174 | 4 payments
|
| Medtronic USA | Activa | $115 | 7 payments
|
| Ucb | Briviact | $104 | 4 payments
|
| Adamas Pharmaceuticals | Gocovri | $52 | 2 payments
|
| Philips Electronics North America | Neuro Equip | $40 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $20 | 1 payment
|
| Aquestive Therapeutics | Sympazan | $18 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $18 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $12 | 1 payment
|
Professional record
- NPI
- 1427347053
- Licence
- CA 1065661
- Trained
- Stanford University School of Medicine, 2011
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2011-04-05
- NPI last updated
- 2022-06-02
- NPI record certified
- 2022-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Drive, Stanford, CA, 94305
This office lists an electronic records connection.